Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
99.79
+1.39 (1.41%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Revolution Medicines Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
883
Market Cap
19.78B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Incyte | 5.14B |
| Genmab | 3.72B |
| BioNTech SE | 3.70B |
| BioMarin Pharmaceutical | 3.22B |
| Royalty Pharma | 2.38B |
| Moderna | 1.94B |
| Ionis Pharmaceuticals | 943.71M |
| Ascendis Pharma | 845.52M |
RVMD News
- 6 days ago - Revolution Medicines, Inc. (RVMD) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 12 days ago - Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress - GlobeNewsWire
- 13 days ago - Revolution Medicines to Participate in TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 19 days ago - Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2025 After Market Close on February 25, 2026 - GlobeNewsWire
- 26 days ago - Revolution Medicines, Inc. (RVMD) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript - Seeking Alpha
- 4 weeks ago - Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 5 weeks ago - Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance - Seeking Alpha